OTC - ACTIVE INGREDIENT SECTION
ACTIVE INGREDIENTS: ENSULIZOLE 1.5%, HOMOSALATE 1.0 %, OCTINOXATE 7.5%, OXYBENZONE 4.5%, TITANIUM DIOXIDE 1.17%.
Supremacie
- Manufacturer
- Ventura International LTD
- Effective date
- 2010-02-19
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 01:54:20
Label at a glance#
ProductSupremacie NX Jour
Active ingredientEnsulizole, Homosalate, Octinoxate, Oxybenzone, Titanium Dioxide
Label structure7 sections
Label contents#
Full prescribing information#
INACTIVE INGREDIENT SECTION
INACTIVE INGREDIENTS: AQUA (WATER), CYCLOPENTASILOXANE, C12-15 ALKYL BENZOATE, PISUM SATIVUM (PEA) EXTRACT, CYCLOHEXASILOXANE, GLYCERIN, CETYL ALCOHOL, TRIETHANOLAMINE, PROPYLENE GLYCOL, GLYCERYL STEARATE, METHYL METHACRYLATE CROSSPOLYMER, PHENOXYETHANOL, SODIUM POLYSTYRENE SULFONATE, ERYTHRITOL, PEG-75 STEARATE, XANTHAN GUM, PARFUM (FRAGRANCE), TRIFOLIUM PRATENSE (CLOVER) FLOWER EXTRACT, METHYLPARABEN, ACRYLATES/ C10-30 ALKYL ACRYLATE CROSSPOLYMER, SORGHUM BICOLOR STALK JUICE, HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER, STEARIC ACID, PROPYLPARABEN, SILICA, SQUALANE, METHICONE, STEARETH-20, CETETH-20, DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER, DIMETHICONE CROSSPOLYMER, CHLORPHENESIN, BUTYLENE GLYCOL, BUTYLPARABEN, SORBIC ACID, TETRASODIUM EDTA, ISOBUTYLPARABEN, ETHYLPARABEN, POLYSORBATE 60, HYDROLYZED ALGIN, DIMETHICONOL, CHLORELLA VULGARIS EXTRACT, MARIS AQUA (SEA WATER) , LECITHIN, CARBOMER, HOMARINE HCl, CI 19140 (YELLOW 5), BIOTINOYL TRIPEPTIDE-1, CI 14700 (RED 4).
SPL UNCLASSIFIED SECTION
INGREDIENTS: AQUA (WATER), ETHYLHEXYL METHOXYCINNAMATE, BENZOPHENONE-3, CYCLOPENTASILOXANE, C12-15 ALKYL BENZOATE, PISUM SATIVUM (PEA) EXTRACT, CYCLOHEXASILOXANE, GLYCERIN, CETYL ALCOHOL, TRIETHANOLAMINE, PHENYLBENZIMIDAZOLE SULFONIC ACID, TITANIUM DIOXIDE, PROPYLENE GLYCOL, HOMOSALATE, GLYCERYL STEARATE, METHYL METHACRYLATE CROSSPOLYMER, PHENOXYETHANOL, SODIUM POLYSTYRENE SULFONATE, ERYTHRITOL, PEG-75 STEARATE, XANTHAN GUM, PARFUM (FRAGRANCE), TRIFOLIUM PRATENSE (CLOVER) FLOWER EXTRACT, METHYLPARABEN, ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER, SORGHUM BICOLOR STALK JUICE, HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER, STEARIC ACID, PROPYLPARABEN, SILICA, SQUALANE, METHICONE, STEARETH-20, CETETH-20, DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER, DIMETHICONE CROSSPOLYMER, CHLORPHENESIN, BUTYLENE GLYCOL, BUTYLPARABEN, SORBIC ACID, TETRASODIUM EDTA, ISOBUTYLPARABEN, ETHYLPARABEN, POLYSORBATE 60, HYDROLYZED ALGIN, DIMETHICONOL, CHLORELLA VULGARIS EXTRACT, MARIS AQUA (SEA WATER), LECITHIN, CARBOMER, HOMARINE HCl, CI 19140 (YELLOW 5), BIOTINOYL TRIPEPTIDE-1, CI 14700 (RED 4).
INDICATIONS & USAGE SECTION
USE: Use in the morning after cleanser and toner. Apply a small quantity with your fingertips, spreading it over your face with rising, circular movements. Massage in gently to help facilitate absorption.
WARNINGS SECTION
WARNING: For external use only. Avoid contact with eyes. Keep out of reach of children. If you observe any adverse reaction, discontinue use and consult your physician.
SPL UNCLASSIFIED SECTION
IMPORTANT: Provides moderate protection against sunburn.
- HYPOALLERGENIC.
- DERMATOLOGICALLY AND CLINICALLY TESTED.
PRINCIPAL DISPLAY PANEL - 50 mL Carton
L'BEL
PARIS
SUPRÉMACIE NX JOUR
traitement reconstituant
crème de jour pour le visage
fps 15
peau normale à grasse
replenishing treatment
daytime face cream spf 15
normal to oily skin
tratamiento reconstituyente
crema facial de día fps 15
cutis normal a graso
50 ml e (1.6 fl. oz.)
FDA-Initiated Inactive NDC Indexing#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Ensulizole | ACTIVE INGREDIENT | 9YQ9DI1W42 | 1 | |
| Homosalate | ACTIVE INGREDIENT | V06SV4M95S | 1 | |
| Octinoxate | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| Oxybenzone | ACTIVE INGREDIENT | 95OOS7VE0Y | 1 | |
| Titanium Dioxide | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| Ensulizole | ACTIVE MOIETY | 9YQ9DI1W42 | 1 | |
| Homosalate | ACTIVE MOIETY | V06SV4M95S | 1 | |
| Octinoxate | ACTIVE MOIETY | 4Y5P7MUD51 | 1 | |
| Oxybenzone | ACTIVE MOIETY | 95OOS7VE0Y | 1 | |
| Titanium Dioxide | ACTIVE MOIETY | 15FIX9V2JP | 1 |
Products#
Every source-derived product name is available through these pages.
- Supremacie NX Jour
- Ensulizole, Homosalate, Octinoxate, Oxybenzone, and Titanium Dioxide
- Ensulizole
- Homosalate
- Octinoxate
- Oxybenzone
- Titanium Dioxide
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 14783-093 | 14783-093-93, 14783-093-94, 14783-093-95, 14783-093-96, 14783-093-97 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Ensulizole | 9YQ9DI1W42 | ACTIB |
| Homosalate | V06SV4M95S | ACTIB |
| Octinoxate | 4Y5P7MUD51 | ACTIB |
| Oxybenzone | 95OOS7VE0Y | ACTIB |
| Titanium Dioxide | 15FIX9V2JP | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 358583f2-8797-3121-e063-6294a90a11be | 5c5ac0e9-b284-4363-8a82-1e2183ef992d | 2025-05-19 | Warnings | 5c5ac0e9-b284-4363-8a82-1e2183ef992d |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.